Interview with Dr. Jerry Avorn on the 21st Century Cures Act’s potential implications for drug development and safety. (08:23)Download In recent months, the FDA has declined to permit use of eight new sunscreen ingredients (that are already in use in Europe) without additional data. The controversy says as much about how the agency works as it does about sunscreen regulation.
No takes yet. Share an insight, caveat, or question.
Avorn et al. (2015) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: